A new case confirming and expanding the phenotype spectrum of ADAT3-related intellectual disability syndrome.


Journal

European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 26 07 2018
revised: 30 09 2018
accepted: 04 10 2018
pubmed: 9 10 2018
medline: 7 2 2020
entrez: 9 10 2018
Statut: ppublish

Résumé

The present study describes two patients with clinical diagnosis of ID, from a consanguineous family in Israel. Whole exome sequencing identified a homozygous missense mutation in the ADAT3 gene. The clinical features of our patients were compared with several cases described in two recently published studies that documented clinical manifestation of this same mutation. Both affected siblings in our study expressed the previously described clinical features such as intellectual disability, strabismus, FTT/underweight, microcephaly and hypotonia. Interestingly, our patients suffered from additional clinical manifestations that were not detailed in the previous two studies, such as: gait difficulties, instability, teeth abnormalities, neuropathy and contractures of the hand wrist and fingers. We conclude that the ADAT3 gene mutation is responsible for ADAT3-related ID syndrome, which induces the variety clinical manifestations exhibited by our patients. Further studies aimed at identifying and characterizing additional afflicted families worldwide will be required to obtain a more comprehensive understanding of this syndrome.

Identifiants

pubmed: 30296593
pii: S1769-7212(18)30574-3
doi: 10.1016/j.ejmg.2018.10.001
pii:
doi:

Substances chimiques

RNA-Binding Proteins 0
ADAT3 protein, human EC 3.5.4.4
Adenosine Deaminase EC 3.5.4.4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103549

Informations de copyright

Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Auteurs

Rajech Sharkia (R)

The Triangle Regional Research and Development Center, P. O. Box-2167, Kafr Qari, 30075, Israel; Beit-Berl Academic College, Beit-Berl, 44905, Israel. Electronic address: rajachsharkia@hotmail.com.

Abdelnaser Zalan (A)

The Triangle Regional Research and Development Center, P. O. Box-2167, Kafr Qari, 30075, Israel.

Azhar Jabareen-Masri (A)

The Triangle Regional Research and Development Center, P. O. Box-2167, Kafr Qari, 30075, Israel.

Hazar Zahalka (H)

Child Neurology and Development Center, Hillel-Yaffe Medical Center, Hadera, 38100, Israel.

Muhammad Mahajnah (M)

Child Neurology and Development Center, Hillel-Yaffe Medical Center, Hadera, 38100, Israel; Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH